Gastrointestinal Protection: May help protect the gut lining, reduce ulcer formation, and improve gut health
Linciano P, Sorbi C, Rossino G, Rossi D, Marsala A, Denora N, et al
The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
-(Standardized to 80 mg Silymarin Flavonoids - equivalent 80%)
With a molecular weight of approximately 4963 Da this protein fragment is relevant for research
In Labortests und Tiermodellen zeigt BPC-157 mehrere Mechanismen: Es aktiviert den Stickstoffmonoxid-Signalweg (wichtig fr Durchblutung), frdert die Blutgefbildung durch VEGFR2-Aktivierung, moduliert Entzndungsreaktionen und zeigt neuroprotektive Effekte
